| 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2 A D’Avolio, V Avataneo, A Manca, J Cusato, A De Nicolò, R Lucchini, ... Nutrients 12 (5), 1359, 2020 | 556 | 2020 |
| In vitro activity of propolis againstStreptococcus pyogenes K Bosio, C Avanzini, A D'avolio, O Ozino, D Savoia Letters in applied microbiology 31 (2), 174-177, 2000 | 308 | 2000 |
| Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients S Cosma, AR Carosso, J Cusato, F Borella, M Carosso, M Bovetti, ... American journal of obstetrics and gynecology 224 (4), 391. e1-391. e7, 2021 | 168 | 2021 |
| Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations S Rodríguez-Nóvoa, P Labarga, A D'avolio, P Barreiro, M Albalate, ... Aids 24 (7), 1064-1066, 2010 | 167 | 2010 |
| HPLC–MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients A D’Avolio, M Siccardi, M Sciandra, B Lorena, S Bonora, L Trentini, ... Journal of Chromatography B 859 (2), 234-240, 2007 | 146 | 2007 |
| New HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma S De Francia, A D’Avolio, F De Martino, E Pirro, L Baietto, M Siccardi, ... Journal of Chromatography B 877 (18-19), 1721-1726, 2009 | 135 | 2009 |
| A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir … A Ariaudo, F Favata, A De Nicolò, M Simiele, L Paglietti, L Boglione, ... Journal of pharmaceutical and biomedical analysis 125, 369-375, 2016 | 134 | 2016 |
| An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 … A D'Avolio, L Baietto, M Siccardi, M Sciandra, M Simiele, V Oddone, ... Therapeutic Drug Monitoring 30 (6), 662-669, 2008 | 131 | 2008 |
| Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19 M Tempestilli, P Caputi, V Avataneo, S Notari, O Forini, L Scorzolini, ... Journal of Antimicrobial Chemotherapy 75 (10), 2977-2980, 2020 | 110 | 2020 |
| HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions A D’Avolio, M Simiele, M Siccardi, L Baietto, M Sciandra, S Bonora, ... Journal of pharmaceutical and biomedical analysis 52 (5), 774-780, 2010 | 108 | 2010 |
| Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study A Berruti, N Fazio, A Ferrero, MP Brizzi, M Volante, E Nobili, L Tozzi, ... BMC cancer 14, 1-10, 2014 | 97 | 2014 |
| Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma L Baietto, A D’Avolio, FG De Rosa, S Garazzino, M Michelazzo, ... Analytical and bioanalytical chemistry 396, 791-798, 2010 | 93 | 2010 |
| Association of a Single-Nucleotide Polymorphism in the Pregnane X Receptor (PXR 63396C→T) with Reduced Concentrations of Unboosted Atazanavir M Siccardi, A D'Avolio, L Baietto, S Gibbons, M Sciandra, D Colucci, ... Clinical infectious diseases 47 (9), 1222-1225, 2008 | 93 | 2008 |
| A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics? L Baietto, S Corcione, G Pacini, G Di Perri, A D’Avolio, ... Current drug metabolism 15 (6), 581-598, 2014 | 92 | 2014 |
| Population pharmacokinetic modeling of the association between 63396C→ T pregnane X receptor polymorphism and unboosted atazanavir clearance A Schipani, M Siccardi, A D'Avolio, L Baietto, M Simiele, S Bonora, ... Antimicrobial agents and chemotherapy 54 (12), 5242-5250, 2010 | 91 | 2010 |
| LC-MS application for therapeutic drug monitoring in alternative matrices V Avataneo, A D’Avolio, J Cusato, M Cantù, A De Nicolò Journal of pharmaceutical and biomedical analysis 166, 40-51, 2019 | 90 | 2019 |
| HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC) A D’Avolio, M Simiele, S De Francia, A Ariaudo, L Baietto, J Cusato, ... Journal of pharmaceutical and biomedical analysis 59, 109-116, 2012 | 90 | 2012 |
| Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2 … V Avataneo, A de Nicolo, J Cusato, M Antonucci, A Manca, A Palermiti, ... Journal of Antimicrobial Chemotherapy 75 (7), 1772-1777, 2020 | 89 | 2020 |
| Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy A Yilmaz, C Verhofstede, A D'Avolio, V Watson, L Hagberg, D Fuchs, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (5), 590-596, 2010 | 86 | 2010 |
| Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect A De Nicolò, M Cantù, A D’Avolio Bioanalysis 9 (14), 1093-1105, 2017 | 83 | 2017 |
